US vaccine maker Moderna set to sign US$1 billion Shanghai deal in major inroad into China’s healthcare market

US vaccine maker Moderna is expected to sign an agreement with the Shanghai government as early as Wednesday to invest about US$1 billion in the commercial hub of China as it promotes mRNA (messenger ribonucleic acid)-based products in the world’s second-largest economy.

The company’s CEO Stephane Bancel has landed in Shanghai to seal the investment deal, according to two people with knowledge of the matter.

The signing of the foreign direct investment (FDI) deal comes after Moderna set up a legal entity in Shanghai earlier this year for what it described as a preliminary step to engage in the Chinese market.

The US$1 billion would be ploughed into several vaccine development and manufacturing projects, the sources said, without elaborating.

A sign marks the headquarters of Moderna in Cambridge, Massachusetts, United States, pictured on May 18, 2020. Photo: Reuters
A sign marks the headquarters of Moderna in Cambridge, Massachusetts, United States, pictured on May 18, 2020. Photo: Reuters

Neither the Shanghai municipal government, nor Moderna has responded to queries by the Post yet.

Source link

Visited 1 times, 1 visit(s) today

Related Article

Hong Kong rents fourth least affordable globally, Bangkok tops list: DWS study

Hong Kong rents fourth least affordable globally, Bangkok tops list: DWS study

Hong Kong remains one of the world’s least affordable housing rental markets as constrained median household incomes are unable to keep up with limited availability and high demand in the city, according to German asset manager DWS. Three of the five least affordable housing rental markets were in Asia, with Bangkok and Mumbai taking up

A person sits at a desk using their laptop and looks at a stock chart on a second monitor.

If I Could Only Buy and Hold a Single Stock, This Would Be It.

Investors can instantly diversify their portfolios with this low-cost exchange-traded fund. Investing in the stock market is a great way to build long-term wealth. While short-term trading is tempting, the real power of investing lies in a disciplined, patient approach. By focusing on a diversified portfolio of stocks with varying attributes, investors can smooth out

We have the most nuclear weapons

The American President says he hopes to “do a deal on everything” with China. Others are reading now On Wednesday, Trump told reporters that the United States has “more nuclear weapons” than China but said he hopes to reach agreements with Beijing “on everything.” “We’ll make a deal on, I think, everything,” he said. “I

Hong kong

Travel Alert: Hong Kong Confirms First Fatality From Chikungunya – What You Must Know NOW!

Home » Hong Kong News » Travel Alert: Hong Kong Confirms First Fatality From Chikungunya – What You Must Know NOW! Published on October 24, 2025 By: Paramita Sarkar In a shocking development, Hong Kong has confirmed the first death due to travel-related chikungunya, highlighting growing concerns over this debilitating disease. The health department’s announcement

The Hong Kong International Optical Fair opens in early November

The Hong Kong International Optical Fair opens in early November

HONG KONG – Media OutReach Newswire – 24 October 2025 – Organised by the Hong Kong Trade Development Council (HKTDC) and co-‑organised by the Hong Kong Optical Manufacturers Association, the 33rd Hong Kong International Optical Fair will be held from 5 to 7 November 2025 at the Hong Kong Convention and Exhibition Centre. The fair

Kirkmuirhill Men's Shed buy local pub

Kirkmuirhill Men’s Shed buy local pub

Their near £100,000 purchase of Kirkmuirhill Inn means the thriving group can flit from their cramped accommodation next door. The Men’s Shed, who offer activities such as woodcraft and walking, were formed six years ago with a handful of members, but now have 57 signed up.(Image: WSH]) Kirkmuirhill villagers no longer need an excuse to

TSMC’s Q3 2025 Results Couldn’t Lower China Concerns — TradingView News

TSMC’s Q3 2025 Results Couldn’t Lower China Concerns — TradingView News

Source: Leverage Shares analysis While the Taiwan-listed ticker soared before moderating in the present week, the U.S.-listed ticker (wherein each ADS comprises of 5 ordinary shares) showed a distinctly bearish flavour. The factors behind this are directly related to the outlook on AI chip buy-ins as well as the ongoing U.S.-China trade tensions. Trend Analysis